Similar Papers

Paper Title
Journal
Date
Author
The hidden threat of hepatitis B.
The Lancet Global Health
The Lancet. Global health | VOL. 4
The Lancet Global Health The Lancet Global Health
01 Aug 2016
Dichloroacetate enhances the anti-tumor effect of sorafenib via modulating the ROS-JNK-Mcl-1 pathway in liver cancer cells
Liangbo Sun ... Jiqin Lian
Experimental Cell Research | VOL. 406
Liangbo Sun, et. al.Liangbo Sun ... Jiqin Lian
29 Jul 2021
Treatment for liver cancer: From sorafenib to natural products.
Shuli Man ... Ganggang Zhao
European journal of medicinal chemistry | VOL. 224
Shuli Man, et. al.Shuli Man ... Ganggang Zhao
01 Nov 2021
THE USE OF MEDICATIONS IN THE LAST 24 HOURS OF LIFE IN THE ACUTE HOSPITAL SETTING—A DESCRIPTIVE COMPARISON OF CANCER AND NON CANCER PATIENTS USING DATA FROM THE NATIONAL CARE OF THE DYING AUDIT HOSPITALS—ENGLAND (NCDAH) 2013/14
K Tewani ... D Lowe
BMJ Supportive & Palliative Care | VOL. 5
K Tewani, et. al.K Tewani ... D Lowe
01 Mar 2015
View more papers

More From: Journal of Chinese Pharmaceutical Sciences

Paper Title
Journal
Date
Author
Investigation of the apoptotic mechanism in hippocampal and retinal neurons of db/db mice induced by Dihuangyinzi decoction
-
Journal of Chinese Pharmaceutical Sciences | VOL. 33
--
10 Oct 2024
Clinical and experimental investigations into the immune modulatory effects of Qianjinba polysaccharides on a rheumatoid arthritis mouse model: in vivo and in vitro studies
-
Journal of Chinese Pharmaceutical Sciences | VOL. 33
--
10 Oct 2024
Elucidating the therapeutic mechanism of Cang Zhu and Huang Bai in rheumatoid arthritis: a comprehensive analysis integrating network pharmacology and GEO data
-
Journal of Chinese Pharmaceutical Sciences | VOL. 33
--
10 Oct 2024
Solvation dynamics of furazolidone in pure organic solvents and aqueous EDTA disodium salt mixtures: molecular interactions and thermodynamic insights
-
Journal of Chinese Pharmaceutical Sciences | VOL. 33
--
10 Oct 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.